Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VCE Capital Partners is a venture capital firm based in the Southeastern United States that focuses on early-stage and expansion-stage investments in the life sciences and technology sectors. The firm is primarily known for managing specialized investment vehicles, including Louisiana Ventures, LP and Themelios Venture Partners, LP, which were established to commercialize research from institutions such as the Pennington Biomedical Research Center and Louisiana State University. VCE Capital Partners provides equity capital to companies with proprietary technology platforms and has been a founding investor in biotechnology startups like Esperance Pharmaceuticals. The firm's principals have a history of bridging the gap between academic laboratory discoveries and the commercial healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VCE Capital Partners.